Efficacy of Galcanezumab for Migraine Prevention in Patients With Anxiety and/or Depression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies
Headache 2020 Nov 01;60(10)2202-2219, TA Smitherman, GE Tietjen, K Schuh, V Skljarevski, S Lipsius, DN D'Souza, EM PearlmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.